← back to search

Haodong Wang

Ningbo University · CN
Area of research
Computer Vision and Pattern Recognition · Cancer Research
Research interest
Research focused on Matrine and Auxetics, with related work in Docking (animal), Hsp90, Honeycomb. Notable publications include 'Design, synthesis, and biological evaluation of matrine derivatives possessing piperazine moiety as antitumor agents', 'New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment', and 'Electret‐Inspired Charge‐Injected Hydrogel for Scar‐Free Healing of Bacterially Infected Burns Through Bioelectrical Stimulation and Immune Modulation'.
h-index
citations
125
works
9
NIH funding
primary concept
email

Recent publications

Electret‐Inspired Charge‐Injected Hydrogel for Scar‐Free Healing of Bacterially Infected Burns Through Bioelectrical Stimulation and Immune Modulation
Advanced Science 2025cited by 17position: middledoi
Windmill-shaped metamaterials achieving negative thermal expansion
Engineering Structures 2025cited by 16position: middledoi
Bow-inspired auxetic structure with stable auxetics and low stress concentration
International Journal of Mechanical Sciences 2025cited by 4position: middledoi
A novel hierarchical auxetic star-shaped honeycomb with enhanced stiffness
Smart Materials and Structures 2025cited by 3position: middledoi
Novel matrinic acid derivatives bearing 2‐anilinothiazole structure for non‐small cell lung cancer treatment with improved Hsp90 targeting effect
Drug Development Research 2022cited by 13position: middledoi
New modification strategy of matrine as Hsp90 inhibitors based on its specific L conformation for cancer treatment
Bioorganic & Medicinal Chemistry 2020cited by 18position: middledoi
Design, synthesis, and biological evaluation of matrine derivatives possessing piperazine moiety as antitumor agents
Medicinal Chemistry Research 2019cited by 22position: middledoi
Novel indolo-sophoridinic scaffold as Topo I inhibitors: Design, synthesis and biological evaluation as anticancer agents
European Journal of Medicinal Chemistry 2018cited by 16position: middledoi
Novel α, β-Unsaturated Sophoridinic Derivatives: Design, Synthesis, Molecular Docking and Anti-Cancer Activities
Molecules 2017cited by 16position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yiming Xu · Virginia Commonwealth University5 papers (2017–2022)Lisheng Wang · Guangzhou University of Chinese Medicine5 papers (2017–2022)Haroon Ur Rashid · Guangxi University4 papers (2017–2020)Peng Xie · Guangxi University3 papers (2017–2019)Lichuan Wu · Guangxi University3 papers (2017–2019)Yilin Zhu · National University of Singapore3 papers (2025–2025)Jun Jiang · Nanchang University3 papers (2017–2019)Fucong Lu · Guangxi University3 papers (2025–2025)Chuanbiao Zhang · Guangxi University2 papers (2025–2025)Dewang Jing · Guangxi University2 papers (2018–2020)Xu Liu · Guangxi University2 papers (2017–2018)Xu Liu · Nanjing University of Chinese Medicine1 papers (2022–2022)Gan Qiu · Guangxi University1 papers (2022–2022)He Yi · Guangxi University1 papers (2025–2025)Hang Dai · Guangxi University1 papers (2017–2017)Shuyan Zhang · University of Illinois Urbana-Champaign1 papers (2019–2019)Mingyan Gao · Guangxi University1 papers (2017–2017)Tinghui Wei · Guangxi University1 papers (2025–2025)Xiaole Liang · The First Affiliated Hospital, Sun Yat-sen University1 papers (2018–2018)Yongji Wu · Guangxi University1 papers (2020–2020)